The recently released LR Health & Beauty Q3 2025 Results offer a clear snapshot of how one of Europe’s leading direct-selling and social commerce companies is navigating a tough global economy. While the company experienced both revenue and EBITDA declines, leadership remains confident in achieving its 2025 full-year forecast.
The third quarter of 2025 was challenging for many consumer goods brands across Europe, and LR Health & Beauty was no exception. The company confirmed a 4.9% revenue decline in Q3 and a 1.8% dip over the first nine months (9M). EBITDA also dropped sharply.
Yet despite these setbacks, LR reaffirmed its full-year targets,sending a strong signal of confidence in its strategic roadmap.
Founded in 1985, LR operates across 32 countries, supported by over 1,200 employees and thousands of independent partners.
Global Footprint & Business Structure
LR specializes in:
All sold through a hybrid of direct selling and digital social commerce.
Core Product Segments & Innovation
LR is known for top-tier aloe vera formulations, produced in Europe’s leading aloe processing facility.
Digital Social Commerce Model
Its technology-driven model empowers distributors with:
Q3 2025 Revenue Analysis
9M 2025 Revenue Trends
This decline reflects broader consumer hesitation driven by inflation and reduced spending power across Europe.
Type | Q3 2025 | Q3 2024 |
Reported | €2.9M | €7.3M |
Normalized | €3.8M | €8.7M |
Type | 9M 2025 | 9M 2024 |
Reported | €16.3M | €19.0M |
Normalized | €19.1M | €23.1M |
Macroeconomic Pressures
Europe’s consumer market in 2025 is marked by:
Marketing & Sales Expense Surge
LR increased promotional spending, which temporarily hurt profitability.
Market Slowdowns
Some regions experienced declining partner activity.
Offset Gains from New Product Launches
New fragrance collections performed well but couldn’t fully counter market softness.
Despite challenges, the company reaffirmed:
Revenue Projection:
€276M – €281M
EBITDA Projection:
€17M – €20M
CEO Jörg Körfer’s Strategic Vision
He emphasizes strengthening the company’s:
The tone remains optimistic, despite financial setbacks.
Strengthening Capital & Financing Structure
LR aims to stabilize liquidity while supporting future growth.
Efficiency & Operational Optimizations
Cost controls and internal restructuring are underway.
Digital Transformation Through LR neo
The LR neo platform is central to partner productivity and scalability.
The LR Health & Beauty Q3 2025 Results paint a picture of a company weathering economic turbulence while investing heavily in digital tools, product innovation, and long-term stability. While declines in EBITDA and revenue are notable, LR’s strategic clarity, strong leadership, and powerful global brand position it to rebound in the coming quarters.
With digital transformation accelerating and consumer interest in wellness rising, LR’s next phase could unlock significant growth,if operational efficiencies take hold.
There are no reviews yet. Be the first one to write one.
